Skip to main content
Saptaparni Ghosh, et al., The Oncologist
Currently, there are no guidelines for chemotherapy administration in hepatitis C virus-positive patients with breast cancer. This article addresses the knowledge gap, comparing breast cancer patients with and without concurrent hepatitis C virus to determine level of tolerance to treatment.
In this month's blog post, Don Dizon and his colleague Mary Anne Fenton discuss her career in oncology and how the profession has changed over the past 20 years.
In this month's blog, Don Dizon and patient advocate Stacey Tinianov reflect on the power words can have when communicating about cancer with patients. They also discuss how the meaning of words can be fluid and dependent on individual context.
In this month's blog post, Don Dizon discusses advocacy with Young Survival Coalition CEO, Jennifer Merschdorf.
As we monitor and respond to the COVID-19 outbreak, we at AlphaMed Press know how important every update and new piece of information is to reaching the goal of ending this pandemic. Below you can find helpful links to the latest research and findings.
Immunotherapy enhances a cancer patient’s immune system to fight an array of cancers. Immune checkpoint blockade can, however, induce inflammatory side effects known as immune-related Adverse Events (irAE). Because these rare but serious complications need to be quickly detected and properly treated, The Oncologist is devoting a new series designed to enhance the care of patients who may well benefit from therapeutic strategies that involve one or more these powerful immunotherapies.
Precision Medicine Clinic: Molecular Tumor Board is a case-based series designed to help clinicians optimize molecular testing for their patients. The Editors of The Oncologist encourage institutions to share their findings and experiences to help improve the precision of genomic oncology and fulfill its promise of improved outcomes for patients. This collection highlights a diverse set of patients exhibiting a range of tumor types and mutations.
Opioids form the cornerstone of pain management in cancer patients, but the crisis of opioid addiction has resulted in significant challenges facing patients, physicians, lawmakers, and communities across the nation. This series is focused to help clinicians manage the opioid crisis while ensuring adequate pain management for their patients.
Copyright © The Oncologist Community 2020. All rights reserved.